Stimulation of cytokine release and adhesion molecule expression by products of viridans streptococci

被引:9
作者
Hanage, WP [1 ]
Cohen, J [1 ]
机构
[1] Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England
基金
英国医学研究理事会;
关键词
D O I
10.1086/338375
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The viridans streptococci (VS) are associated with the development of a rapidly fulminant shock syndrome in neutropenic patients. A panel of 52 VS strains isolated from the blood of neutropenic patients was used to demonstrate the ability of culture supernatants and cell walls of VS to induce release of the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-8 from whole blood in a dose- and strain-dependent fashion. Intercellular adhesion molecule-1 was shown to be markedly up-regulated on endothelial cells after incubation with plasma from blood exposed to cell walls or culture supernatants. This up-regulation was blocked by IL-1 receptor antagonist but not neutralizing antibody against TNF-alpha. These data may help explain the pathogenesis of the viridans streptococcal shock syndrome in neutropenic patients.
引用
收藏
页码:357 / 367
页数:11
相关论文
共 44 条
[1]   LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND REGULATION OF LEUKOCYTE MIGRATION [J].
ADAMS, DH ;
SHAW, S .
LANCET, 1994, 343 (8901) :831-836
[2]  
BEUTLER B, 1993, CRIT CARE MED, V21, pS423
[3]   STIMULATION OF MONOKINE PRODUCTION BY LIPOTEICHOIC ACIDS [J].
BHAKDI, S ;
KLONISCH, T ;
NUBER, P ;
FISCHER, W .
INFECTION AND IMMUNITY, 1991, 59 (12) :4614-4620
[4]   BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS - A REVIEW [J].
BOCHUD, PY ;
CALANDRA, T ;
FRANCIOLI, P .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (03) :256-264
[5]   BACTEREMIA DUE TO VIRIDANS STREPTOCOCCUS IN NEUTROPENIC PATIENTS WITH CANCER - CLINICAL SPECTRUM AND RISK-FACTORS [J].
BOCHUD, PY ;
EGGIMAN, P ;
CALANDRA, T ;
VANMELLE, G ;
SAGHAFI, L ;
FRANCIOLI, P .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :25-31
[6]  
BRAUDE S, 1985, LANCET, V1, P1239
[7]  
CARLOS TM, 1994, BLOOD, V84, P2068
[8]   PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER [J].
COMETTA, A ;
ZINNER, S ;
DEBOCK, R ;
CALANDRA, T ;
GAYA, H ;
KLASTERSKY, J ;
LANGENAEKEN, J ;
PAESMANS, M ;
VISCOLI, C ;
GLAUSER, MP ;
GIBSON, B ;
SANZ, M ;
HANN, IM ;
FOLLATH, F ;
FATIO, R ;
FERSTER, A ;
VANHOOF, A ;
VANLANDUYT, H ;
ARENDT, V ;
HEMMER, R ;
PEETERMANS, M ;
PADMOS, A ;
SEITANIDES, B ;
HATZIYANNI, M ;
LOPEZ, A ;
PORCELLINI, A ;
GREK, V ;
CABALLERO, D ;
TOGNI, P ;
GALLAGHER, JG ;
GARAVENTA, A ;
MASSIMO, L ;
SUGAR, A ;
LEGRAND, JC ;
OPPENHEIM, B ;
PETRIKKOS, G ;
BEYTOUT, J ;
NIKOSKELAINEN, J ;
SHAPIRO, M ;
ESTAVOYER, JM ;
KERN, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :445-452
[9]   Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America [J].
Diekema, DJ ;
Beach, ML ;
Pfaller, MA ;
Jones, RN .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) :152-157
[10]   Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States [J].
Doern, GV ;
Ferraro, MJ ;
Brueggemann, AB ;
Ruoff, KL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :891-894